For the Inventor, By the Inventor

Enter assignee name

Blacksburg, VA, United States of America

Landos Biopharma, Inc.

USPTO Granted Patents = 18

CIPO Patents = 1

EPO Patents = 3

Trademarks = 5

Forward Citations = 53

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Josep Bassaganya-Riera (18 out of 37 patents)

Raquel Hontecillas (18 out of 31 patents)

Andrew Leber (11 out of 16 patents)

4. Adria Carbo Barrios (7 out of 9 patents)

5. Richard Gandour (7 out of 12 patents)

6. Julian D Cooper (7 out of 12 patents)

7. Nuria Tubau-Juni (2 out of 3 patents)

18 patents: Sort by Forward Citations

1. 11680045 - NLRX1 ligands (2023-06-20),

2. 11597717 - Substituted imidazoles as PLXDC2 ligands (2023-03-07),

3. 11571419 - Lanthionine synthetase C-like 2-based therapeutics (2023-02-07),

4. 11548885 - NLRX1 ligands (2023-01-10),

5. 11492342 - Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone) (2022-11-08),

6. 11459310 - LANCL ligands (2022-10-04),

7. 11377437 - Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same (2022-07-05),

8. 11197891 - Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith (2021-12-14),

9. 11117881 - Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same (2021-09-14),

10. 11066364 - NLRX1 ligands (2021-07-20),

11. 10849895 - Lanthionine synthetase C-like 2-based therapeutics (2020-12-01),

12. 10682349 - Lanthionine synthetase C-like 2-based therapeutics (2020-06-16),

13. 10676436 - NLRX1 ligands (2020-06-09),

14. 10493072 - Lanthionine synthetase C-like 2-based therapeutics (2019-12-03),

15. 10487057 - NLRX1 ligands (2019-11-26),

Landos Biopharma, Inc. is a biotechnology company focused on discovering and developing oral therapeutics for autoimmune diseases. Leveraging their proprietary AI-driven discovery platform, Landos aims to revolutionize the treatment of various autoimmune conditions. Their innovative approach combines computational biology, therapeutic design, and precision medicine to develop highly targeted and effective therapies. With a strong pipeline and a team of experienced scientists and professionals, Landos is committed to improving the lives of patients suffering from autoimmune disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

18 Patents

#8 in Blacksburg, VA

#306 in Virginia

#17,414 in US

#33,184 in the World

Blacksburg, VA, United States of America

Landos Biopharma, Inc.

Forward Citations = 53

7 inventors:

Josep Bassaganya-Riera (18 out of 37 patents)

Raquel Hontecillas (18 out of 31 patents)

Andrew Leber (11 out of 16 patents)

4. Adria Carbo Barrios (7 out of 9 patents)

5. Richard Gandour (7 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…